Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Widimsky, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Widimsky, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Pharmacological versus catheter-based reperfusion: What is present state of the art?

P. Widimsky1

Cardiocentre, Královské Vinohrady University Hospital, Prague, Czech Republic

1 Correspondence: Professor Petr Widimsky, MD, DrSc, FESC, Cardiocentre, University Hospital Vinohrady, Srobárova 50, CZ-100 34 Prague, Czech Republic

Abstract

The aim of any reperfusion therapy is quick and complete restoration of normal (TIMI-grade 3) coronary flow. At least 12 randomized studies have shown, that direct (primary) coronary angioplasty is more effective than any pharmacological approach and should be the preferred reperfusion therapy whenever available with no more than 30–60 min delay (compared with thrombolysis). Immediate knowledge of the coronary anatomy with the possibility of performing coronary bypass surgery in selected patients adds substantially to the overall benefits of the primary angioplasty strategy. Stent implantation markedly decreases the restenosis rate after primary angioplasty. The benefits of primary angioplasty are sustained in long-term follow-up. The extent of benefit from primary angioplasty is dependent on the time delay and on the operator experience, but it appears that even low-volume operators achieve similar or slightly better results than the most effective thrombolytic regimens. Thrombolysis is preferred therapy only for patients with timely access to primary angioplasty, especially when they are treated within initial 4 h of symptoms. The role of GPIIb/IIIa receptor inhibitors in conjunction with primary angioplasty or stenting is promising, but additional studies should confirm whether it is useful routinely for all patients or selectively only for the ‘extreme hypercoagulation’ situation and/or for ‘suboptimal angioplasty/stent result’.

Key Words: Acute myocardial infarction • reperfusion therapy • primary angioplasty • rescue angioplasty • stent • thrombolysis

References

  1. De Wood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 1980;303:897–902[Abstract]
  2. Cazov EL, Matveeva LS, Mazaev AV, Sargin KE, Sadovskaia GV, Ruda MI. Vnutrikoronarnoje vvedenije fibrinolysina pri ostrom infarkte myokarda. Ter Arkh. 1976;48:8–19
  3. Rentrop P, Blanke H, Kostering H, Karsch KR. Intracoronary application of streptokinase in acute myocardial infarction and non-stable and agnina pectoris. Dtsch Med Wochenschr. 1980;105:221–228[Medline]
  4. Kinn JW, O'Neill WW, Benzulyj KH, Jones DE, Grines CL. Primary angioplasty reduces risk of myocardial rupture compared to thrombolysis for acute myocardial infarction. Cath Cardiovasc Diagn. 1997;42:151–157[CrossRef][Web of Science][Medline]
  5. Shah A, Wagner GS, Granger CB, et al. Prognostic implications of TIMI flow grade in the infarct-related artery compared with continuous 12-lead ST-segment resolution analysis. J Am Coll Cardiol. 2000;35:666–672[Abstract/Free Full Text]
  6. Wehrens XH, Doevendans PA, Ophuis TJ, Wellens HL. A comparison of electrocardiographic changes during reperfusion of acute myocardial infarction by thrombolysis or percutaneous transluminal coronary angioplasty. Am Heart J. 2000;139:430–436[CrossRef][Web of Science][Medline]
  7. Pucci PD, Antoniucci D, Boddi V, et al. La rapida riduzione del sovraslivellamento del tratto ST e predittiva del recupero della fanzione nell'infarto miocardico acuto trattato noc angioplastica coronarcia primaria. G Ital Cardiol. 1998;28:554–563[Medline]
  8. French JK, Stránický IT, Webber BJ, et al. Angiographic frame counts 90 min after streptokinase predicts left ventricular function at 48 h following myocardial infarction. Heart. 1999;81:128–133[Abstract/Free Full Text]
  9. Morishima I, Sone T, Okumura K, et al. Angiographic noreflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol. 2000;36:1202–1209[Abstract/Free Full Text]
  10. Gruppo Italiano per to Studio della Streptochinasi nell'infarto miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986;i:397–402
  11. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2:349–360[Medline]
  12. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673–682[Abstract/Free Full Text]
  13. Randomized double-blind comparison of reteplase double bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. International Joint Efficacy Comparison of Thrombolytics. Lancet. 1995;346:329–336[CrossRef][Web of Science][Medline]
  14. The Global Use of Strategy To Open Occluded Coronary Artery (GUSTO III) Investigators. A comparison of reteplase with alteplase for acute myocardial Infarction. N Engl J Med. 1997;337:1118–1123[Abstract/Free Full Text]
  15. Braunwald E, Neuhaus KL, Antman E, et al. Intravenous NPA for the treatment of infarcting myocardium early — InTIME-II, a double-blind comparison of single-bolus lanote plase vs. accelerated alteplase for the treatment of patients with acute myocardial infarction. Eur Heart J. 2000;21:2005–2013[Abstract/Free Full Text]
  16. ASSENT-2 Investigators. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomized trial. Lancet. 1999;354:716–722[CrossRef][Web of Science][Medline]
  17. SPEED Group. Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Circulation. 2000;101:2788–2794[Abstract/Free Full Text]
  18. Zeymer U. Intro-AMI (Integrilin and reduced dose of thrombolytics for acute myocardial infarction). Circulation. 1999;100:E131
  19. Zijlstra F, de Boer MJ, Hoorntje ICA, Reiffers S, Reiber JHC, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 1993;328:680–684[Abstract/Free Full Text]
  20. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 1993;328:673–679[Abstract/Free Full Text]
  21. Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfenspirger MR, Gersh BJ. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med. 1993;328:685–691[Abstract/Free Full Text]
  22. GUSTO-11b Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med. 1997;336:1621–1628[Abstract/Free Full Text]
  23. Weaver W, Simes RJ, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA. 1997;278:2093–3098[Abstract/Free Full Text]
  24. Zijlstra F, Hoorntje JC, de Boer MJ, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 1999;341:1413–1419[Abstract/Free Full Text]
  25. Nunn CM, O'Neill WW, Rothbaum D, et al. Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trial. J Am Coll Cardiol. 1999;33:640–646[Abstract/Free Full Text]
  26. Vermeer F, Oude Ophuis AJ, vd Berg EJ, et al. Prospective randomized comparison between thrombolytics, rescue PTCA and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study. Heart. 1999;82:426–431[Abstract/Free Full Text]
  27. Widimský P, Groch L, elízko M, Aschermann M, Bedá F, Suryapranata HPRAGUE Study Group. Multicenter randomized trial comparing transport to primary angioplasty vs. immediate thrombolysis vs. combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. Eur Heart J. 2000;21:823–831[Abstract/Free Full Text]
  28. Berger PB, Ellis SG, Holmes DR Jr, et al. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the GUSTO-11b trial. Circulation. 1999;100:14–20[Abstract/Free Full Text]
  29. Barron HV, Rundle A, Gurwitz J, Tiefenbrunn A. Reperfusion therapy for acute myocardial infarction: observations from the National Registry of Myocardial Infarction-2. Cardiol Rev. 1999 May–Jun;7(3):156–160[Medline]
  30. Hochman IS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. N Engl J Med. 1999;341:625–634[Abstract/Free Full Text]
  31. Horie H, Takahashi M, Minai K, et al. Long-term beneficial effect of late reperfasion for acute anterior myocardial infarction with percutaneous transluminal coronary angioplasty. Circulation. 1998;98:2377–2382[Abstract/Free Full Text]
  32. Peterson LR, Chandra NC, French WJ, Rogers WJ, Weaver WD, Tiefenbrunn AL. Reperfasion therapy in patients with acute myocardial infarction and prior coronary artery bypass graft surgery (NRMI-2). Am J Cardiol. 1999;84:1287–1291[CrossRef][Web of Science][Medline]
  33. Grines CL, Cox DA, Stone GWStent-PAMI Study Group. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med. 1999;341:1949–1956[Abstract/Free Full Text]
  34. Antoniucci D, Santoro GM, Bolognese L, Valenti R, Trapani M, Fazzini PF. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: results from the FRESCO trial. J Am Coll Cardiol. 1998;31:1234–1239[Abstract/Free Full Text]
  35. Suryapranata H, van't Hof AW, Hoorntje JC, de Boer ML, Zijlstra F. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation. 1998;97:2502–2505[Abstract/Free Full Text]
  36. Maillard L, Hamon M, Khalife K, STENTIM-2 Investigators. A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2000;35:1729–1736[Abstract/Free Full Text]
  37. Barragan P, Montalescot G, Wittenberg O, et al. Abciximab associated with primary angioplasty and stenting in acute myocardial infarction. The ADMIRAL study, 6 month results. Circulation. 2000;102:3208
  38. Stone GW, Stenting and IIb/IIIa Receptor Blockade in Acute Myocardial Infarction: An Introduction to the CADILLAC Trial. J Invasive Cardiol. 1998 April;10(Suppl B):36B–47B
  39. Schomig A, Kastrati A, Dirschinger J, et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. STOPAMI Study Investigators. N Engl J Med. 2000;343:385–391[Abstract/Free Full Text]
  40. Stone GW, Brodie BR, Griffin JJ, et al. Role of cardiac surgery in the hospital phase management of patients treated with primary angioplasty for acute myocardial infarction. Am J Cardiol. 2000;85:1292–1296[CrossRef][Web of Science][Medline]
  41. McCullough PA, et al. A prospective randomized trial of triage angiography in suspected acute myocardial infarction patients, who are considered ineligible for reperfasion therapy. Circulation. 1996;94:I–570
  42. Scull GS, Martin IS, Weaver WD, Every NR. Early angiography versus conservative treatment in patients with non-ST elevation acute myocardial infarction: MITI Investigators. Myocardial Infarction Triage and Intervention. J Am Coll Cardiol. 2000 Mar 15;35(4):903–906
  43. paek R, Widimský P, Straka Z, et al. Value of First Day Angiography/Angioplasty In Evolving Non-ST Segment Elevation Myocardial Infarction. An Open Multicenter Randomized Trial. VINO Study. Ear Heart J in press.

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JAMAHome page
U. Stenestrand, J. Lindback, L. Wallentin, and for the RIKS-HIA Registry
Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction.
JAMA, October 11, 2006; 296(14): 1749 - 1756.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Widimsky, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Widimsky, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?